April 8, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, is proud to announce a philanthropic global health collaboration with RAD-AID International. RAD-AID, a non-profit charitable organization dedicated to improving radiology healthcare in medically underserved regions, is collaborating with iCAD to introduce mammography AI-based decision support in LMICs, starting with an implementation in Guyana using iCAD’s ProFound Detection.
The partnership’s primary goal is to improve the speed, efficiency and accuracy of breast imaging and breast cancer detection by providing low-resource medical institutions with access to technology, education, clinical support, and hands-on training. iCAD and RAD-AID aim to begin in Guyana where implementation of iCAD’s ProFound AI Detection Solution, coupled with RAD-AID’s educational and capacity-building initiatives, aims to increase, and improve breast cancer detection for patients in need. Such collaboration endeavors to build AI-supported models for globally reducing health care disparities and increasing health equity by widening access to earlier cancer diagnostics.
“Breast cancer remains a significant global health challenge, particularly in regions where trained clinical personnel and technological resources are scarce and drive deep disparities in breast cancer outcomes.” said Daniel Mollura, M.D., RAD-AID Founder and CEO. “By integrating iCAD’s ProFound Detection AI algorithm into mammography workflows in low-resource institutions, along with RAD-AID’s support for radiology education, patient-navigation, and medical imaging capacity-building, we aim to improve early cancer detection and save more lives. We are grateful for this support from iCAD, which advances RAD-AID’s mission to expand health equity for those living and working in medically underserved communities.”
"Dedicated to our mission of creating a world where cancer can’t hide and one where every woman has access to quality care, iCAD is honored to partner with RAD-AID on this transformative program to ensure advances in early cancer detection are available globally,” said Dana Brown, President and CEO of iCAD. “Our deployment of ProFound AI Detection in Guyana represents a significant step forward in the fight against breast cancer in low-resource settings. Together with RAD-AID, we can revolutionize breast cancer detection accuracy and efficiency, ensuring medical professionals have the training and the tools they need to work smarter. When it comes to a cancer diagnosis, we believe where you live should not determine whether you live.”
Both iCAD and RAD-AID will be attending the 2024 SBI Breast Imaging Symposium from April 11-14 at the Palais des Congrès de Montréal (Montréal Convention Centre). The meeting theme is “Reimagining Breast Imaging - Seeing Opportunities Together” which perfectly portrays the essence of this mission-driven partnership.
Connect with us live at SBI - Schedule time to learn about this new partnership via: https://www.icadmed.com/about/news-events/upcoming-tradeshows-and-meetings/sbi-2024/
April 20, 2026 
